Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs ORCHID PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA ORCHID PHARMA CIPLA/
ORCHID PHARMA
 
P/E (TTM) x 32.2 41.8 77.2% View Chart
P/BV x 5.2 7.7 67.1% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 CIPLA   ORCHID PHARMA
EQUITY SHARE DATA
    CIPLA
Mar-23
ORCHID PHARMA
Mar-23
CIPLA/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs1,185439 270.3%   
Low Rs852273 312.0%   
Sales per share (Unadj.) Rs281.9163.1 172.8%  
Earnings per share (Unadj.) Rs35.113.5 259.6%  
Cash flow per share (Unadj.) Rs49.727.0 184.2%  
Dividends per share (Unadj.) Rs8.500-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs289.2168.7 171.4%  
Shares outstanding (eoy) m807.1540.82 1,977.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.62.2 165.7%   
Avg P/E ratio x29.026.3 110.3%  
P/CF ratio (eoy) x20.513.2 155.4%  
Price / Book Value ratio x3.52.1 167.0%  
Dividend payout %24.20-   
Avg Mkt Cap Rs m822,16414,522 5,661.3%   
No. of employees `000NANA-   
Total wages/salary Rs m38,301654 5,860.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m227,5316,659 3,416.9%  
Other income Rs m5,121194 2,635.6%   
Total revenues Rs m232,6536,853 3,394.8%   
Gross profit Rs m48,0791,235 3,892.9%  
Depreciation Rs m11,721548 2,139.4%   
Interest Rs m1,095329 332.9%   
Profit before tax Rs m40,384552 7,309.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m12,0290-   
Profit after tax Rs m28,355552 5,132.4%  
Gross profit margin %21.118.5 113.9%  
Effective tax rate %29.80-   
Net profit margin %12.58.3 150.2%  
BALANCE SHEET DATA
Current assets Rs m168,0515,010 3,354.2%   
Current liabilities Rs m50,3333,719 1,353.4%   
Net working cap to sales %51.719.4 266.8%  
Current ratio x3.31.3 247.8%  
Inventory Days Days7357 127.8%  
Debtors Days Days71,180 0.6%  
Net fixed assets Rs m117,3187,242 1,620.0%   
Share capital Rs m1,614408 395.5%   
"Free" reserves Rs m231,8456,478 3,578.8%   
Net worth Rs m233,4606,886 3,390.1%   
Long term debt Rs m01,488 0.0%   
Total assets Rs m290,06712,252 2,367.5%  
Interest coverage x37.92.7 1,413.4%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.80.5 144.3%   
Return on assets %10.27.2 141.1%  
Return on equity %12.18.0 151.4%  
Return on capital %17.810.5 168.8%  
Exports to sales %22.681.9 27.7%   
Imports to sales %8.937.6 23.6%   
Exports (fob) Rs m51,5165,452 944.9%   
Imports (cif) Rs m20,2022,501 807.7%   
Fx inflow Rs m64,2825,452 1,179.1%   
Fx outflow Rs m20,2022,726 741.1%   
Net fx Rs m44,0802,726 1,617.2%   
CASH FLOW
From Operations Rs m32,377183 17,655.4%  
From Investments Rs m-23,885-312 7,652.0%  
From Financial Activity Rs m-9,583312 -3,074.8%  
Net Cashflow Rs m-968183 -529.1%  

Share Holding

Indian Promoters % 13.4 69.8 19.2%  
Foreign collaborators % 20.0 0.0 -  
Indian inst/Mut Fund % 50.0 18.6 268.2%  
FIIs % 25.7 4.1 621.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.5 30.2 220.6%  
Shareholders   425,731 36,931 1,152.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   DIVIS LABORATORIES    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Cipla vs Orchid Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs Orchid Pharma Share Price Performance

Period Cipla Orchid Pharma S&P BSE HEALTHCARE
1-Day 1.94% -0.40% 1.18%
1-Month 1.25% -14.06% -0.75%
1-Year 68.02% 173.54% 61.82%
3-Year CAGR 22.53% -23.64% 18.16%
5-Year CAGR 23.24% 184.58% 19.79%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the Orchid Pharma share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 33.5% stake in the company. In case of Orchid Pharma the stake stands at 69.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of Orchid Pharma.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 8.5 per share. This amounted to a Dividend Payout ratio of 24.2%.

Orchid Pharma paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Cipla, and the dividend history of Orchid Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.